Hyderabad’s Gland Pharma to make 252 million doses of Sputnik V, Top Health News | Latest Health & Healthcare Industry Information and Updates: ET HealthWorld : ETHealthworld.com

Gland Pharma, which is based out of Hyderabad, has entered into an agreement with Russian sovereign wealth fund, Russian Direct Investment Fund (RDIF), to manufacture and supply 252 million (25.2 crore) doses of Russian Covid-19 vaccine Sputnik V., Gland Pharma, which is based out of Hyderabad, has entered into an agreement with Russian sovereign wealth fund, Russian Direct Investment Fund (RDIF), to manufacture and supply 252 million (25.2 crore) doses of Russian Covid-19 vaccine Sputnik V., , Read More